Cardiovascular disease (CVD) is the biggest contributor to the life expectancy gap across the North West Coast and a major cause of premature death and health inequalities.
Cardiovascular disease (CVD) is the biggest contributor to the life expectancy gap across the North West Coast and a major cause of premature death and health inequalities. Health Innovation North West Coast works with the NHS and Integrated Care Systems to reduce the impact of CVD through prevention, identifying risk earlier, and improving long-term outcomes for patients. Our work is aligned with national NHS ambitions, including the 10 Year Health Plan for England and regional priorities to reduce heart attacks and strokes across.
Cardiovascular is close inter-connected with renal and metabolic conditions. They share common risk factors and are frequently underdiagnosed and undertreated. Around one in three people with cardio renal-metabolic disease live with two or more of these conditions, with a disproportionate impact on deprived and underserved communities.
From 2026/27, our national programmes will expand to include a stronger focus on chronic kidney disease (CKD). Alongside existing CKD improvement work, we will support systems to adopt innovation that enables earlier identification, optimises evidence-based treatment and delivers more proactive, sustainable care at scale.
Find out more about our national and local programmes of work
Atrial Fibrillation
We have contributed to various Atrial Fibrillation focused projects, both nationally and locally.
Blood Pressure
As part of the wider CVD prevention programme, we are supporting local work to reduce hypertension and support primary care colleagues to optimise care for people with high blood pressure.
Chronic Kidney Disease
We are supporting a chronic kidney disease (CKD) project utilising novel smart technology to accurately detect CKD in the community.
Heart Failure
As part of a national Heart Failure (HF) programme, we are supporting local work to promote early diagnosis and optimised long-term management, reduce hospital admissions, and improve the quality of life for patients living with HF.
Lipids Management
We are collaborating with healthcare professionals to reduce cardiovascular risk by improving lipid management and the diagnosis and treatment of Familial Hypercholesterolaemia.
Previous programmes
Long term conditions
Proactive management of Long Term Conditions (LTCS), part of the NHS@Home programme.